Clinical Trials Sponsored by D-Rev

Total 2070 results

Galderma R&D

Completed

Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler (Sculptra)

Gene Expression

United States
Galderma R&D

Completed

Study to Evaluate Satisfaction After Treatment With Restylane

Cheek Augmentation

Canada
Galderma R&D

Completed

Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin

Glabellar Lines

China
Galderma R&D

Completed

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

Acne

United States
Galderma R&D

Completed

An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area

Wrinkles in Decolletage

United States
Galderma R&D

Active, not recruiting

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Chin Retrusion | Chin Augmentation

United States, Puerto Rico
Galderma R&D

Completed

Restylane Defyne Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds

Nasolabial Folds in Chinese Population

China
Galderma R&D

Completed

Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds

Skin Wrinkling

United States
Galderma R&D

Completed

A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Galderma R&D

Active, not recruiting

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Prurigo Nodularis

United States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland, Austria, Denmark, Germany, Hungary, Italy, Sweden, United Kingdom
Galderma R&D

Terminated

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Keratosis, Actinic

United States, Puerto Rico
Galderma R&D

Active, not recruiting

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
Galderma R&D

Completed

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
Galderma R&D

Completed

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
Galderma R&D

Completed

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation (START)

Acne Vulgaris

United States, Canada, France
Galderma R&D

Completed

Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds

Skin Wrinkling

United States
Galderma R&D

Completed

Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects

Acne Vulgaris

United States
Galderma R&D

Completed

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States, Germany
Galderma R&D

Completed

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Prurigo Nodularis

United States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland
Galderma R&D

Completed

Treatment of Moderate to Severe Lateral Canthal Lines (READY-2)

Lateral Canthal Lines

United States, Canada
Galderma R&D

Completed

Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis

Atopic Dermatitis

Canada
Galderma R&D

Completed

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)

Atopic Dermatitis

United States
Galderma R&D

Completed

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
Galderma R&D

Completed

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

Healthy Volunteers

United States
Galderma R&D

Completed

Macrolane VRF30 for Enhancement of Shape and Fullness of Female Breast (COBRA)

Breast Enhancement

Sweden, France
Galderma R&D

Completed

A Study to Evaluate Efficacy and Safety of Macrolane VRF30 for Volume Restoration and Contouring of the Buttocks

Volume Restoration and Shaping of the Buttocks

Belgium, Spain, Sweden
Galderma R&D

Completed

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

Plaque Psoriasis

United States
Galderma R&D

Completed

Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars (OSCAR)

Acne Vulgaris | Atrophic Acne Scars

France, Canada
Galderma R&D

Completed

Macrolane Retrospective Study

Women Who Have Had Breast Enhancement With Macrolane VRF

Sweden
Galderma R&D

Completed

(Macrolane VR30) in Buttocks Reshaping and contouringCellulite (Macrolane VR30) in Buttocks Reshaping and Contouring

Cellulite of the Buttocks

Brazil
Galderma R&D

Completed

An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face

Aged Skin

Germany
Galderma R&D

Completed

Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand

Volume Deficit in the Hand

United States
Galderma R&D

Completed

Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds

Nasolabial Folds in Chinese Population

China
Galderma R&D

Completed

Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

Nasolabial Fold

Taiwan
Galderma R&D

Completed

Study to Evaluate Satisfaction After Treatment With Kysse

Lip Augmentation

Canada
Galderma R&D

Terminated

Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation

Facial Tissue Augmentation

Sweden
Galderma R&D

Completed

A Post Market Evaluation After Treatment of Nasolabial Folds

Nasolabial Folds

China
Galderma R&D

Completed

Perception of Facial Expressions Following Correction of Wrinkles and Folds

Wrinkles and Folds in Lower Face

Germany
Galderma R&D

Completed

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Scalp Psoriasis

United States
Galderma R&D

Completed

Swedish Macrolane Registry

Breast Augmentation

Sweden
Galderma R&D

Completed

Safety and Efficacy Study of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine

Lip Filler Injections

Sweden, Germany
Galderma R&D

Completed

Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

Knee Osteoarthritis

United Kingdom
Galderma R&D

Completed

A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice

Health Knowledge, Attitudes, Practice

France, Germany, Spain, United Kingdom
Galderma R&D

Completed

A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine

Safety

Sweden
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Acne

United States
Galderma R&D

Terminated

Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

Melasma

United States
Galderma R&D

Completed

Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

P Acnes Colonization

United States
Galderma R&D

Completed

Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States

3

Subscribe